Characteristics and Risk Factors for Pediatric Sepsis

Abstract

Objective

Sepsis is considered a major cause of health loss in children and had high mortality and morbidity. Currently, there is no reliable model for predicting the prognosis of pediatric patients with sepsis. This study aimed to analyze the clinical characteristics of sepsis in children and assess the risk factors associated with poor prognosis in pediatric sepsis patients to identify timely interventions and improve their outcomes.

Methods

This study analyzed the clinical indicators and laboratory results of septic patients hospitalized in the Pediatric Intensive Care Unit of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China, from January 1, 2019, to December 31, 2021. Risk factors for sepsis were identified by logistic regression analyses.

Results

A total of 355 children with sepsis were enrolled, with 333 children (93.8%) in the good prognosis group, and 22 children (6.2%) in the poor prognosis group. Among them, there were 255 patients (71.8%) in the sepsis group, and 100 patients (28.2%) in the severe sepsis group. The length of hospital stay in the poor prognosis group was longer than that in the good prognosis group (P<0.01). The levels of interleukin 1β (IL-1β) in the poor prognosis group were higher than those in the good prognosis group (P>0.05), and the platelet (PLT), albumin (ALB), and hemoglobin (Hb) levels were lower in the poor prognosis group (P<0.01). The IL-8 levels in the severe sepsis group were higher than those in the sepsis group (P<0.05). Multiple logistic regression analysis suggested that lower Hb levels, ALB levels, peak PLT counts, and higher IL-1β levels were independent risk factors for poor prognosis in children with sepsis.

Conclusion

Lower Hb, ALB, and PLT counts and elevated IL-1β are independent risk factors for poor prognosis in children with sepsis.

Keywords

pediatric sepsis / inflammation / severity / prognosis / risk factors

References

[1] SingerM, DeutschmanCS, SeymourCW, et al.. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 2016, 315(8): 801-810

[2] RubioI, OsuchowskiMF, Shankar-HariM, et al.. Current gaps in sepsis immunology: new opportunities for translational research. Lancet Infect Dis, 2019, 19(12): e422-e436

[3] YeL, FengM, LinQ, et al.. Analysis of pathogenic factors on the death rate of sepsis patients. PLoS One, 2023, 18(12): e0287254

[4] XiaZF, WuGS. Role of cytokines in sepsis and its current situation of clinical application. Chin J Burns (Chinese), 2019, 35(1): 3-7

[5] AngusDC, Van Der PollT. Severe sepsis and septic shock. N Engl J Med, 2013, 369(9): 840-851

[6] ZhangYY, NingBT. Signaling pathways and intervention therapies in sepsis. Signal Transduct Target Ther, 2021, 6(1): 407

[7] YoshimuraJ, YamakawaK, OguraH, et al.. Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis. Crit Care, 2015, 19(1): 78

[8] SchmidtC. The struggle to do no harm in clinical trials. Nature, 2017, 552(7685): s74-s75

[9] RoncoC, ChawlaL, Husain-SyedF, et al.. Rationale for sequential extracorporeal therapy (SET) in sepsis. Crit Care, 2023, 27(1): 50

[10] XiaoC, WangS, FangF, et al.. Epidemiology of Pediatric Severe Sepsis in Main PICU Centers in Southwest China. Pediatr Crit Care Med, 2019, 20(12): 118-1125

[11] DashefskyHS, LiuH, HayesK, et al.. Frequency of and Risk Factors Associated With Hospital Readmission After Sepsis. Pediatrics, 2023, 152(1): e2022060819

[12] GoldsteinB, GiroirB, RandolphA. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med, 2005, 6(1): 2-8

[13] WangX, LiR, QianS, et al.. Multilevel omics for the discovery of biomarkers in pediatric sepsis. Pediatr Investig, 2023, 7(4): 277-289

[14] SchuurmanAR, ReijndersTDY, KullbergRFJ, et al.. Sepsis: deriving biological meaning and clinical applications from high-dimensional data. Intensive Care Med Exp, 2021, 9(1): 27

[15] KomorowskiM, GreenA, TathamKC, et al.. Sepsis biomarkers and diagnostic tools with a focus on machine learning. EBioMedicine, 2022, 86: 104394

[16] YaoYH, ZhaoJY, HuJH, et al.. Identification of a Four-Gene Signature for Diagnosing Paediatric Sepsis. Biomed Res Int., 2022, 14: 5217885

[17] SunP, CuiM, JingJJ, et al.. Deciphering the molecular and cellular atlas of immune cells in septic patients with different bacterial infections. J Transl Med, 2023, 21(1): 777

[18] AraujoR, BentoLFN, FonsecaTH, et al.. Infection Biomarkers Based on Metabolomics. Metabolites, 2022, 12(2): 92

[19] MiaoH, ChenS, DingRY. Evaluation of the Molecular Mechanisms of Sepsis Using Proteomics. Front Immunol, 2021, 12: 733537

[20] BorghesiA, TrückJ, AsgariS, et al.. Whole-exome Sequencing for the Identification of Rare Variants in Primary Immunodeficiency Genes in Children With Sepsis: A Prospective, Population-based Cohort Study. Clin Infect Dis, 2020, 71(10): e614-e623

[21] SeymourCW, KennedyJN, WangS, et al.. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA, 2019, 321(20): 2003-2017

[22] BhavaniSV, SemlerM, QianET, et al.. Development and validation of novel sepsis subphenotypes using trajectories of vital signs. Intensive Care Med, 2022, 48(11): 582-1592

[23] Van AmstelRBE, KennedyJN, SciclunaBP, et al.. Uncovering heterogeneity in sepsis: a comparative analysis of subphenotypes. Intensive Care Med, 2023, 49(11): 1360-1369

[24] Sanchez-PintoLN, BennetTD, StroupEK, et al.. Derivation, Validation, and Clinical Relevance of a Pediatric Sepsis Phenotype With Persistent Hypoxemia, Encephalopathy, and Shock. Pediatr Crit Care Med, 2023, 24(10): 795-806

[25] AnderkoRR, GómezH, CannaSW, et al.. Sepsis with liver dysfunction and coagulopathy predicts an inflammatory pattern of macrophage activation. Intensive Care Med Exp, 2022, 10(1): 6

[26] ShakooryB, CarcilloJA, ChathamWW, et al.. Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial. Crit Care Med, 2016, 44(2): 275-281

[27] AlcamoAM, BarrenGJ, BeckerAE, et al.. Validation of a Computational Phenotype to Identify Acute Brain Dysfunction in Pediatric Sepsis. Pediatr Crit Care Med, 2022, 23(12): 1027-1036

[28] BasuRK, HackbarthR, GillespieS, et al.. Clinical phenotypes of acute kidney injury are associated with unique outcomes in critically ill septic children. Pediatr Res, 2021, 90(5): 1031-1038

[29] LautzAJ, WongHR, RyanTD, et al.. Pediatric Sepsis Biomarker Risk Model Biomarkers and Estimation of Myocardial Dysfunction in Pediatric Septic Shock. Pediatr Crit Care Med, 2022, 23(1): e20-e28

[30] DengP, TangNN, LiL, et al.. Diagnostic value of combined detection of IL-1β, IL-6, and TNF-α for sepsis-induced cardiomyopathy. Med Clin (Barc), 2022, 158(9): 413-417

[31] KapurR, ZuffereyA, BoilardE, et al.. Nouvelle cuisine: platelets served with inflammation. J Immunol, 2015, 194(12): 5579-5587

[32] ShannonO. The role of platelets in sepsis. Res Pract Thromb Haemost, 2021, 5(1): 27-37

[33] ChenJ, TuX, HuangM, et al.. Prognostic value of platelet combined with serum procalcitonin in patients with sepsis. Medicine, 2023, 102(34): e34953

[34] FogagnoloA, CampoGC, MariM, et al.. The Underestimated Role of Platelets in Severe Infection a Narrative Review. Cells, 2022, 11(3): 424

[35] WorkmanJK, BaillyDK, ReederRW, et al.. Risk Factors for Mortality in Refractory Pediatric Septic Shock Supported with Extracorporeal Life Support. ASAIO J, 2020, 66(10): 1152-1160

[36] ZhengYJ, ZhuXJ, ChenYW, et al.. Establishment of a novel risk score for in-hospital mortality in adult sepsis patients. Ann Transl Med, 2022, 10(14): 781

[37] QiD, PengM. Early Hemoglobin Status as a Predictor of Long-Term Mortality for Sepsis Patients in Intensive Care Units. Shock, 2021, 55(2): 215-223

[38] ChenY, ChenL, MengZ, et al.. The correlation of hemoglobin and 28-day mortality in septic patients: secondary data mining using the MIMIC-IV database. BMC Infect Dis, 2023, 23(1): 417

[39] ManetaE, AivaliotiE, Tual-ChalotS, et al.. Endothelial dysfunction and immunothrombosis in sepsis. Front Immunol, 2023, 14: 1144229

[40] OsterHS, DolevY, KehatO, et al.. Serum Hypoalbuminemia Is a Long-Term Prognostic Marker in Medical Hospitalized Patients, Irrespective of the Underlying Disease. J Clin Med, 2022, 11(5): 1207

[41] HaoJ, ZengJ. Analysis of the clinical characteristics and risk factors associated with the death in 101 children with sepsis. J Pathogen Biol, 2021, 16(4): 486-491

[42] GeY, HuangM, YaoYM. Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis. Cytokine Growth Factor Rev (Chinese), 2019, 45: 24-34

[43] MeraS, TatulescuD, CismaruC, et al.. Multiplex cytokine profiling in patients with sepsis. APMIS, 2011, 119(2): 155-163

[44] FajgenbaumDC, JuneCH. Cytokine Storm. N Engl J Med, 2020, 383(23): 2255-2273

[45] LiuD, HuangSY, SunJH, et al.. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Mil Med Res, 2022, 9(1): 56

[46] Lorente-PozoS, NavarreteP, GarzónMJ, et al.. DNA Methylation Analysis to Unravel Altered Genetic Pathways Underlying Early Onset and Late Onset Neonatal Sepsis. A Pilot Study. Front Immunol, 2021, 12: 622599

[47] MithalLB, ArshadM, SwigartLR, et al.. Mechanisms and modulation of sepsis-induced immune dysfunction in children. Pediatr Res, 2022, 91(2): 447-453

[48] ZhangW, WangW, HouW, et al.. The diagnostic utility of IL-10, IL-17, and PCT in patients with sepsis infection. Front Public Health, 2022, 10: 923457

[49] TuH, LaiX, LiJ, et al.. Interleukin-26 is overexpressed in human sepsis and contributes to inflammation, organ injury, and mortality in murine sepsis. Crit Care, 2019, 23(1): 290

[50] MatsumotoH, OguraH, ShimizuK, et al.. The clinical importance of a cytokine network in the acute phase of sepsis. Sci Rep, 2018, 8(1): 13995

[51] Ben AzaizM, Ben JemaaA, SellamiW, et al.. Deciphering the balance of IL-6/IL-10 cytokines in severe to critical COVID-19 patients. Immunobiology, 2022, 227(4): 152236

[52] ZengL, KangR, ZhuS, et al.. ALK is a therapeutic target for lethal sepsis. Sci Transl Med, 2017, 9(412): eaan5689

[53] Martínez-GarcíaJJ, Martínez-BanaclochaH, Angosto-BazarraD, et al.. P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsis. Nat Commun, 2019, 10(1): 2711

[54] BrownKA, BrownGA, LewisSM, et al.. Targeting cytokines as a treatment for patients with sepsis: A lost cause or a strategy still worthy of pursuit?. Int Immunopharmacol, 2016, 36: 291-299